Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-01-17 4:05 pm Purchase | 13D | ARTARA THERAPEUTICS INC TARA | Flynn James E | 432,670 7.4% | 432,670 (New Position) | View |
| 2019-12-30 08:30 am Purchase | 13D | HOMOLOGY MEDICINES INC FIXX | Flynn James E | 5,245,638 11.91% | 18,603 (+0.36%) | View |
| 2019-12-19 11:22 am Purchase | 13G | NEURONETICS INC STIM | Flynn James E | 1,075,000 5.77% | 1,075,000 (New Position) | View |
| 2019-12-03 10:29 am Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Flynn James E | 1,196,241 7.22% | 348,741 (+41.15%) | View |
| 2019-11-15 5:22 pm Purchase | 13D | ADAPTHEALTH CORP AHCO | Flynn James E | 22,069,166 50.42% | 22,069,166 (New Position) | View |
| 2019-11-13 8:58 pm Unchanged | 13D | PROTEON THERAPEUTICS INC PRTO | Flynn James E | 17,306,917 9.985% | 0 (Unchanged) | View |
| 2019-11-08 4:59 pm Sale | 13G | XERIS PHARMACEUTICALS INC XERS | Flynn James E | 2,420,641 8.97% | -78,025 (-3.12%) | View |
| 2019-11-08 4:34 pm Unchanged | 13D | PROTEON THERAPEUTICS INC PRTO | Flynn James E | 17,306,917 9.985% | 0 (Unchanged) | View |
| 2019-10-30 5:17 pm Purchase | 13G | CABALETTA BIO INC CABA | Flynn James E | 1,628,506 9.5% | 1,628,506 (New Position) | View |
| 2019-10-21 12:42 pm Unchanged | 13D | DFB HEALTHCARE ACQUISITIONS CO DFBHU | Flynn James E | 8,571,739 27.43% | 0 (Unchanged) | View |
| 2019-10-11 4:23 pm Purchase | 13G | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Flynn James E | 2,491,881 5.46% | 2,491,881 (New Position) | View |
| 2019-10-07 4:37 pm Purchase | 13G | FREQUENCY THERAPEUTICS INC FREQ | Flynn James E | 1,231,434 4.04% | 1,231,434 (New Position) | View |
| 2019-08-22 1:30 pm Sale | 13G | AAC HLDGS INC AAC | Flynn James E | 0 0% | -1,936,027 (Position Closed) | View |
| 2019-08-19 07:54 am Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Flynn James E | 1,749,005 5.07% | 811,995 (+86.66%) | View |
| 2019-08-19 07:54 am Purchase | 13G | AXOGEN, INC. AXGN | Flynn James E | 2,469,501 6.29% | 2,469,501 (New Position) | View |
| 2019-07-31 07:18 am Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | Flynn James E | 2,848,374 6.9% | -3,045,042 (-51.67%) | View |
| 2019-07-24 2:21 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | Flynn James E | 3,448,912 14.98% | 3,448,912 (New Position) | View |
| 2019-07-15 2:30 pm Unchanged | 13D | DFB HEALTHCARE ACQUISITIONS CO DFBHU | Flynn James E | 8,571,739 27.43% | 0 (Unchanged) | View |
| 2019-06-17 4:37 pm Purchase | 13G | AERIE PHARMACEUTICALS INC AERI | Flynn James E | 2,932,987 6.39% | 1,414,391 (+93.14%) | View |